ADSK
66
-4
HCA
48
-2
DG
8
-2
PLD
45
-5
DLTR
38
-4
C
62
4
PAYX
48
-6
COST
57
-6
SCHW
62
-2
ADP
65
-3
OXY
36
-2
HRB
59
2
RIG
43
-7
M
31
-3
PSA
56
3
MDLZ
32
-4
SE
60
-3
URI
60
-6
NOV
52
-5
NSC
53
-4
ADSK
66
-4
HCA
48
-2
DG
8
-2
PLD
45
-5
DLTR
38
-4
C
62
4
PAYX
48
-6
COST
57
-6
SCHW
62
-2
ADP
65
-3
OXY
36
-2
HRB
59
2
RIG
43
-7
M
31
-3
PSA
56
3
MDLZ
32
-4
SE
60
-3
URI
60
-6
NOV
52
-5
NSC
53
-4
Financhill
Back

Rivernorth Opportunities Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
50

RIV
Rivernorth Opportunities Fund

Last Price:
12.39
Seasonality Move:
4.65%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
50
Rivernorth Opportunities Fund (RIV) is a Sell

Is Rivernorth Opportunities Fund a Buy, Sell or Hold?

  • The current Rivernorth Opportunities Fund [RIV] share price is $12.39. The Score for RIV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RIV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RIV Stock Price Chart

What is Rivernorth Opportunities Fund's stock price today?

  • The Rivernorth Opportunities Fund share price today is $12.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RIV is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

RIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 40.04 Sell
Chaikin Money Flow: -17802 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.47 - 12.73) Sell
Bollinger Bands (100): (12.22 - 12.68) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

RIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.57 Sell
20-day SMA: 12.56 Sell
50-day SMA: 12.63 Sell
200-day SMA: 12.18 Buy
8-day EMA: 12.55 Sell
20-day EMA: 12.58 Sell
50-day EMA: 12.56 Sell
200-day EMA: 12.19 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Rivernorth Opportunities Fund Earnings Growth & RIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Rivernorth Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):